Detalhe da pesquisa
1.
Allogeneic transplantation after immunotherapy for relapsed/refractory non-Hodgkin lymphoma: a comparison with a historical cohort.
Cytotherapy;
2024 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38775776
2.
Outcome of High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma after Different Numbers of Salvage Regimens.
Cells;
13(2)2024 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38247809
3.
Frontal Lobe Status Epilepticus Related to CAR T-Cell Therapy Responsive to Anakinra.
Can J Neurol Sci;
: 1-3, 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38234097
4.
Editorial: Controversies and expectations for prevention and treatment of graft-versus-host-disease: a biological and clinical perspective.
Front Immunol;
14: 1212756, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37256121
5.
Impact of Preemptive Use of Tocilizumab on Chimeric Antigen Receptor T Cell Outcomes in Non-Hodgkin Lymphoma.
Transplant Cell Ther;
29(7): 429.e1-429.e6, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36966874
6.
EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide.
Bone Marrow Transplant;
58(3): 247-256, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36414698
7.
Selected memory T cells infused post-haploidentical hematopoietic stem cell transplantation persist and hyperexpand.
Blood Adv;
7(14): 3458-3468, 2023 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36469095
8.
Persistence of KIRneg NK cells after haploidentical hematopoietic stem cell transplantation protects from human cytomegalovirus infection/reactivation.
Front Immunol;
14: 1266051, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38268918
9.
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide.
Bone Marrow Transplant;
57(12): 1758-1764, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36057732
10.
Gene Abnormalities in Transplant Associated-Thrombotic Microangiopathy: Comparison between Recipient and Donor's DNA.
Thromb Haemost;
122(7): 1247-1250, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965590
11.
Risk Factors for Early Cytomegalovirus Reactivation and Impact of Early Cytomegalovirus Reactivation on Clinical Outcomes after T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.
Transplant Cell Ther;
28(3): 169.e1-169.e9, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34954296
12.
Feasibility and Efficacy of a Pharmacokinetics-Guided Busulfan Conditioning Regimen for Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Adult Patients with Hematologic Malignancies.
Transplant Cell Ther;
27(11): 912.e1-912.e6, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34403790
13.
Single-cell profiling reveals the dynamics of cytomegalovirus-specific T cells in haploidentical hematopoietic stem cell transplantation.
Haematologica;
106(10): 2768-2773, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34233445
14.
Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis.
Bone Marrow Transplant;
56(11): 2763-2770, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34262142
15.
Single-cell profiling identifies impaired adaptive NK cells expanded after HCMV reactivation in haploidentical HSCT.
JCI Insight;
6(12)2021 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34003794
16.
Feasibility and Efficacy of CD45RA+ Depleted Donor Lymphocytes Infusion After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Patients With Hematological Malignancies.
Transplant Cell Ther;
27(6): 478.e1-478.e5, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33819481
17.
Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis Lymphomas.
Transplant Cell Ther;
27(4): 328.e1-328.e6, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33836877
18.
Nonmyeloablative Conditioning Regimen Including Low-Dose Total Marrow/Lymphoid Irradiation Before Haploidentical Transplantation with Post-Transplantation Cyclophosphamide in Patients with Advanced Lymphoproliferative Diseases.
Transplant Cell Ther;
27(6): 492.e1-492.e6, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33857448
19.
American Society of Hematology 2020 Podcast Collection: Graft-Versus-Host Disease.
Adv Ther;
38(Suppl 1): 36-44, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33783718
20.
Clinical Challenges in an Unusual Setting: ST-Elevation in a Patient Suffering From Graft Versus Host Disease, Between Thrombosis and Coronary Spasm.
Cardiovasc Revasc Med;
28S: 239-242, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33612413